1-4 of 4
Ian D Lewis, MB, BS, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Dose Cytarabine (HiDAC) and Fludarabine Without Anthracycline For Patients With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): The Australasian Leukaemia and Lymphoma Group (ALLG) AMLM13 Study

Paula Marlton, MBBS, John F Seymour, MBBS, PhD, Kenneth Bradstock, MBBS, PhD, Ian D Lewis, MB, BS, PhD, Russell Saal, BAppSci, MMedSci, Lyle McMillen, BSc, PhD, Juliana Di Iulio, BAppSc, PhD, Diana Zannino, BSc, MSc, Andrew Grigg, MBBS
Journal: Blood
Blood (2013) 122 (21): 1444.
https://doi.org/10.1182/blood.V122.21.1444.1444
Published: 2013
Journal Articles

Epigenetic Deregulation In Relapsed Acute Myeloid Leukemia

Francine E. Garrett-Bakelman, MD, PhD, Sheng Li, Todd Hricik, Stephen S. Chung, MD, Haim Bar, PhD, Anna L Brown, PhD, Jay P. Patel, Franck Rapoport, PhD, Lin Liu, Caroline Sheridan, Jennifer Ishii, Paul Zumbo, Jorge Gandara, Ian D Lewis, MB, BS, PhD, Luen Bik To, MD, Michael W. Becker, MD, Monica L. Guzman, PhD, Richard J D'Andrea, PhD, Franziska Michor, PhD, Christopher Y. Park, MD, PhD, Martin Carroll, MD, Ross L. Levine, MD, Christopher E Mason, PhD, Ari M. Melnick, MD
Journal: Blood
Blood (2013) 122 (21): 2499.
https://doi.org/10.1182/blood.V122.21.2499.2499
Published: 2013
Journal Articles

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

Jeffrey E Lancet, MD, Andrew H Wei, MBBS, PhD, Simon TS Durrant, Mark S. Hertzberg, MBBS, PhD, FRACP, FRCPA, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Ian D Lewis, MB, BS, PhD, Brian Jonas, MD, PhD, Jorge E. Cortes, MD, Geoffrey Yarranton, PhD, Jackie M. Walling, MBChB, PhD
Journal: Blood
Blood (2013) 122 (21): 3838.
https://doi.org/10.1182/blood.V122.21.3838.3838
Published: 2013
Journal Articles

A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies

Stephen Couban, MD, Mahmoud Aljurf, Silvy Lachance, MD, Irwin Walker, MBBS, Cynthia L. Toze, MD, FRCP(C), Morel Rubinger, MD, Jeff H. Lipton, PhD, MD, Stephanie J. Lee, MD, MPH, Jeffrey Szer, MD, Richard Doocey, Ian D Lewis, MB, BS, PhD, Lothar B. Huebsch, MD, Kang Howson-Jan, MD, Faisal Al Mohareb, MD, Naeem Chaudhri, MD, Aminia Kariminia, PhD, Sabine Ivison, PhD, Diane L. Fairclough, PhD, Gerald Devins, David Szwajcer, MD, FRCPC, Stephen Ronan Foley, MD, FRCPC, Clayton A. Smith, MD, FRCPC, Tony Panzarella, M.Sc, Holly Margaret Kerr, RN, BSN, Kirk R. Schultz, MD
Journal: Blood
Blood (2013) 122 (21): 709.
https://doi.org/10.1182/blood.V122.21.709.709
Published: 2013